TIRZEPATIDE
Clinical trials for TIRZEPATIDE explained in plain language.
Never miss a new study
Get alerted when new TIRZEPATIDE trials appear
Sign up with your email to follow new studies for TIRZEPATIDE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Weight-Loss drug tirzepatide tested in kidney transplant patients
Disease control Recruiting nowThis pilot study tests the safety and effectiveness of tirzepatide (Spartina) for weight loss in 30 obese adults who have had a kidney transplant at least a year ago. Participants receive weekly injections for 24 weeks, with dose adjustments based on tolerance. Researchers will t…
Matched conditions: TIRZEPATIDE
Phase: PHASE4 • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
Brain scans reveal effects of pausing Weight-Loss drug
Knowledge-focused Recruiting nowThis study will follow 40 adults aged 18-70 who currently take tirzepatide, a medication for blood sugar and appetite control. Researchers will temporarily stop the drug for 3-4 weeks and then restart it for 6-8 weeks, using brain scans, questionnaires, and stool samples to track…
Matched conditions: TIRZEPATIDE
Phase: NA • Sponsor: The University of Texas at Dallas • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC